Background: The healthcare sector witnessed the occurrences and impacts of disruptions on supply chains during the coronavirus disease (COVID-19) pandemic. Consequently, it is essential to strengthen institutional medical supply chain systems by addressing the key attributes of strategic stockpile plan renewal: flexibility, traceability and transparency, perseverance and responsiveness, global independence, and equitable access.
Aim and objective: To establish a resilient supply chain integrated into the emergency management cycle by proposing a sustainable 5P Strategic Medical Stockpile model.
Settings: Online evidence, available literature, and lessons learned during the COVID-19 response in the Emirate of Abu Dhabi.
Methods: This review employed a systematic methodology of identification, selection, assessment, synthesis, and interpretation of data from peer-reviewed articles, review reports, and response frameworks spanning the years 2012 to 2020. Additionally, media reports and announcements were analyzed to determine the implications of COVID-19 on the supply chain from 2020 to 2022. Recommendations are formulated in response to the identified shortcomings revealed during the review process, as well as considering experiences and lessons resulting from responses to address COVID-19 in the Abu Dhabi Health Sector.
Results: Our analysis revealed a deficiency in effective operational protocols for building a robust supply chain. The experience gained from responding to COVID-19 has highlighted deficiencies such as unclear issues with stockpiles, inadequate resources, insufficient planning, the absence of established procedures, and a lack of performance monitoring. The pandemic had a tremendous impact on health systems and medical supply chains worldwide. Our suggested model necessitates aligning responses with national contingency protocols. Accountability may fluctuate during each phase of an emergency, depending on decision-making authority and jurisdictional capabilities.
Conclusion: The proposed 5P model can support policymakers, health regulators, institutions, and professionals in formulating strategies to establish a resilient stockpile system that serves as a medical supply chain buffer when supplies are not instantly accessible.
Key words: Counterfeit, Emergency response, Policymakers, Resilient supply chain, Shortage, Strategic Medical Stockpile.
|
